Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Satralizumab, a humanized monoclonal antibody and potent Interleukin-6 (IL-6) inhibitor, prevents the formation and progression of descending thoracic aorta aneurysm (dTAA) in Rattus norvegicus. It is also used in research for neuromyelitis optica spectrum disorder (NMOSD) and dTAA [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Satralizumab, a humanized monoclonal antibody and potent Interleukin-6 (IL-6) inhibitor, prevents the formation and progression of descending thoracic aorta aneurysm (dTAA) in Rattus norvegicus. It is also used in research for neuromyelitis optica spectrum disorder (NMOSD) and dTAA [1] [2]. |
Molecular Weight | N/A |
CAS No. | 1535963-91-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Satralizumab 1535963-91-7 inhibitor inhibit